Effective Orifice Area Index Calculator

Slides:



Advertisements
Similar presentations
Sibbing D, et al. J Am Coll Cardiol 2009;53:
Advertisements

How to Avoid Prosthesis-Patient Mismatch
University Heart Center Hamburg
Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis George L. Zorn, III.
Valve Design and Clinical Results “Our Experience, Your Advantage”
Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.
INTERNATIONAL. CAUTION: For distribution only in markets where CoreValve® is approved. Not for distribution in U.S., Canada or Japan. Medtronic, Inc
Prostate Cancer Symposium An Educational Initiative For Patients, Spouses, Advocates and Healthcare Professionals Importance of Clinical trials Virgil.
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Transcatheter Valve-in-Valve and Valve-in-Ring for.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Predicting the Unpredictable: Drug-Induced QT Prolongation.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Choice of Prosthetic Heart Valve in Adults: An Update.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Translation of Human-Induced Pluripotent Stem Cells:
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Overview of the 2011 Food and Drug Administration.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Renal Sympathetic Denervation on Arterial.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: The STS-ACC Transcatheter Valve Therapy National.
Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Emerging Role of Exercise Testing and Stress.
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: Choice of Prosthetic Heart Valve in Adults: An Update.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Choice of prosthetic heart valve for adult patients.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Embolic Cerebral Insults After Transapical Aortic.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Optimal Implantation Depth and Adherence to Guidelines.
J Am Coll Cardiol. Published online September 28, doi: /j.jacc
Longest Follow-up After Implantation of a Self-Expanding Repositionable Transcatheter Aortic Valve: Final Follow-up of the Evolut R CE Study Stephen Brecker,
What should be the optimal Design for TAVI Procedure.
Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.
OUS Data: What does the CE Mark Really Mean?
Copyright © 2015 by the American Osteopathic Association.
Review of the Latest OUS Data from the Self-Expanding Valve Studies
TAVI „Catch me if you can!“
First-in-Man, First In The USA: What’s The Difference?
Murat Ugur, MD, Rakesh M. Suri, MD, DPhil, Richard C
Preliminary experience with the St
Contribution of Three-Dimensional Transesophageal Echocardiography to Diagnosis and Management of Thrombosis of a St. Jude Mechanical Prosthesis in the.
Energy Loss Index in Aortic Stenosis
Figure 5 TAVI with a self-expanding valve in
Totally Supra Annular Mechanical Heart Valves
Nat. Rev. Cardiol. doi: /nrcardio
Scott Goldman, MD, Anson Cheung, MD, Joseph E. Bavaria, MD, Michael R
Sorin Bicarbon: 17 years of clinical use
FDA Medical Device Approval Pathways
Current Therapy for Type II Diabetes
Figure 2 Three-year survival rates on the basis of body composition
Figure 4 Effects of delaying cardioprotective medications after anthracycline administration Figure 4 | Effects of delaying cardioprotective medications.
Professional Organizations
Niyada Naksuk et al. JACEP 2016;2:
Orientation of tilting disc and bileaflet aortic valve substitutes for optimal hemodynamics  Joachim Laas, MD, Peter Kleine, MD, Michael J Hasenkam, MD,
Prospective randomized comparison of CarboMedics and St
Mitral valve-in-valve hemodynamic performance: An in vitro study
A Patient Has a 3-Centimeter Cecal Polyp on Chronic Anticoagulation for a Mechanical Mitral Valve Prosthesis  Andrew J. Overhiser, Douglas K. Rex  Clinical.
Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age  Alberto.
June 2012 Living Environment Regents
January 2013 Living Environment Regents
Where is the common sense in aortic valve replacement
Nominal size in six bileaflet mechanical aortic valves: a comparison of orifice size and biologic equivalence  John B Chambers, MD, FACC, Lionel Oo, FRCS,
The St Jude Medical Trifecta aortic pericardial valve: Results from a global, multicenter, prospective clinical study  Joseph E. Bavaria, MD, Nimesh D.
Early hemodynamic performance of the third generation St Jude Trifecta aortic prosthesis: A systematic review and meta-analysis  Kevin Phan, BS, Hakeem.
Assessment of effective orifice area of prosthetic aortic valves with Doppler echocardiography: An in vivo and in vitro study  Odd Bech-Hanssen, MD, PhDa,
Outcomes after mechanical aortic valve replacement in children and young adults with congenital heart disease  Patrick O. Myers, MD, Suyog A. Mokashi,
Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled.
Baseline Clinical Characteristics
Outcome analysis of 245 CarboMedics and St
In vitro comparison of different mechanical prostheses suitable for replacement of the systemic atrioventricular valve in children  Tomaso Bottio, MD,
Nat. Rev. Cardiol. doi: /nrcardio
Comparison of hemodynamic performances of St
St Jude Medical Regent valve
Hemodynamics and early clinical performance of the St
Effect of Prosthesis-Patient Mismatch on Long-Term Survival With Aortic Valve Replacement: Assessment to 15 Years  W.R. Eric Jamieson, MD, Jian Ye, MD,
Stephen Westaby, Hans A Huysmans, Tirone E David 
Clinical outcome in patients with 19-mm and 21-mm St
Pasquale Totaro, MD, Vincenzo Argano, MD 
A randomized comparison of the MCRI On-X and CarboMedics Top Hat bileaflet mechanical replacement aortic valves: Early postoperative hemodynamic function.
Presentation transcript:

Effective Orifice Area Index Calculator To change patient data, click figure, change data in Excel and close Excel to return to presentation References: 1. St. Jude Medical Inc., Pre-Market Approval Application - Summary of Safety and Effectiveness: 2002. Washington D.C.; Food and Drug Administration, 2002, P810002/S057. MCRI, Pre-Market Approval Application - Summary of Safety and Effectiveness: 2001 Washington D.C.; Food and Drug Administration, 2001, P000037. Carbomedics Inc., Pre-Market Approval Application - Summary of Safety and Effectiveness: 1993. Washington D.C.; Food and Drug Administration, 1993, P900060. ATS Medical Inc., Pre-Market Approval Application - Summary of Safety and Effectiveness: 2000. Washington D.C.; Food and Drug Administration, 2000, P990046. Baxter Healthcare Corporation, Pre-Market Approval Application - Summary of Safety and Effectiveness: 1991 Washington D.C.; Food and Drug Administration, 1991, P860057. Medtronic Inc., Pre-Market Approval Application - Summary of Safety and Effectiveness: 2000 Washington D.C.; Food and Drug Administration, 2000, P990064. 2. Pibarot P, Dumesnil JG.; Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention, J Am Coll Cardiol 2000 Oct;36(4):1131-41.

Effective Orifice Area Index Calculator SJM Regent Key: EOAI < .80 cm2/m2 .80 cm2/m2 <= EOAI <= .85 cm2/m2 EOAI > .85 cm2/m2

Effective Orifice Area Index Calculator MCRI On-X Key: EOAI < .80 cm2/m2 .80 cm2/m2 <= EOAI <= .85 cm2/m2 EOAI > .85 cm2/m2

Effective Orifice Area Index Calculator ATS Standard Key: EOAI < .80 cm2/m2 .80 cm2/m2 <= EOAI <= .85 cm2/m2 EOAI > .85 cm2/m2

Effective Orifice Area Index Calculator CMI TopHat Key: EOAI < .80 cm2/m2 .80 cm2/m2 <= EOAI <= .85 cm2/m2 EOAI > .85 cm2/m2

Effective Orifice Area Index Calculator CMI (Std/R) Key: EOAI < .80 cm2/m2 .80 cm2/m2 <= EOAI <= .85 cm2/m2 EOAI > .85 cm2/m2

Effective Orifice Area Index Calculator Edwards Perimount Key: EOAI < .80 cm2/m2 .80 cm2/m2 <= EOAI <= .85 cm2/m2 EOAI > .85 cm2/m2

Effective Orifice Area Index Calculator Medtronic Mosaic Key: EOAI < .80 cm2/m2 .80 cm2/m2 <= EOAI <= .85 cm2/m2 EOAI > .85 cm2/m2

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.